Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO
10:30am, Wednesday, 19'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") (NASDAQ:NVO). Such investors
NVO LAWSUIT ALERT: Levi & Korsinsky Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline
10:20am, Wednesday, 19'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities law
NVO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Novo Nordisk A/S to Contact the Firm Today!
10:00am, Wednesday, 19'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo No
A Rip Van Winkle Portfolio: Invest In These Companies And Forget You Did It
08:00am, Wednesday, 19'th Feb 2025
The Rip Van Winkle portfolio advocates for long-term, buy-and-hold investing in companies with competitive advantages, reasonable valuations, and strong financial performance. Alphabet, Meta, and Alib
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Nordisk A/S Lawsuit – NVO
09:45pm, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities law
Investors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO
08:45pm, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities law
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO
06:21pm, Tuesday, 18'th Feb 2025
NEW YORK , Feb. 18, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") (NASDAQ: NVO). Such investors are advise
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit.
Shareholders that lost money on Novo Nordisk A/S (NVO) should contact Levi & Korsinsky about pending Class Action - NVO
01:15pm, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities law
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo N
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE:NVO) between November 2, 2022 an
Investors who Lost Money on Novo Nordisk A/S (NVO) Should Contact Levi & Korsinsky About Pending Class Action - NVO
12:30pm, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities law
NVO Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / February 18, 2025 / Novo Nordisk A/S (NYSE:NVO) is facing a class-action lawsuit from investors who alleg
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities law
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Novo Nordisk A/S
11:00am, Tuesday, 18'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Novo Nordisk A/S ("Novo"
